Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival

Annals of Surgery

Volumn 244, Issue 3, 2006, Pages 439-448

  Tector, A Joseph ^a   Mangus, Richard S ^a   Chestovich, Paul ^a   Vianna, Rodrigo ^a   Fridell, Jonathan A ^a   Milgrom, Martin L ^a   Sanders, Carrie ^a   Kwo, Paul Y ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HYPERTENSIVE FACTOR; SODIUM;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BILIRUBIN BLOOD LEVEL; BODY MASS; CANCER; CHRONOLOGY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; GROUPS BY AGE; HEART DEATH; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HYPERNATREMIA; IMMUNOCOMPETENT CELL; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; ISCHEMIA; KAPLAN MEIER METHOD; LIVER FUNCTION TEST; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; ORGAN DONOR; POPULATION STRUCTURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SODIUM BLOOD LEVEL; STANDARD; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; WAITING LISTS;

EID: 33747654443     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000234896.18207.fa     Document Type: Review

References (31)

1. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology. 1982;2:614-636.
2. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg. 1999;229:313-321.
3. Miller C, Florman S, Kim-Schluger L, et al. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl. 2004;10:1315-1319.
4. Miller CM. Regulation and oversight of adult living donor liver transplantation. Liver Transpl. 2003;9(suppl 2):69-72.
5. Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance: strategies for achieving organ safety and for increasing organ pool. Clin Transplant. 2003;17:308-324.
6. Renz JF Kin C, Kinkhabwala M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.Ann Surg.2005;242:556-563;discussion 563-565.
7. Bernat JL, D'Alessandro AM, Port FK, et al. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006;6:281-291.
8. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651-663.
9. Cameron A, Busuttil RW. AASLD/ILTS transplant course: is there an extended donor suitable for everyone? Liver Transpl. 2005;11(suppl 2):2-5.
10. Cuende N, Grande L, Sanjuan F, et al. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation. 2002;73:1360.
11. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790.
12. Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242:724-731.
13. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999;5:421-428.
14. Mor E, Klintmalm GB, Gonwa TA, et al. The use of marginal donors for liver transplantation: a retrospective study of 365 liver donors. Transplantation. 1992;53:383-386.
15. Wall WJ, Mimeault R, Grant DR, et al. The use of older donor livers for hepatic transplantation. Transplantation. 1990;49:377-381.
16. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.Ann Surg.2005;241:905-916;discussion 916-918.
17. Lake JR, Shorr JS, Steffen BJ, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant. 2005;5:549-557.
18. Marroquin CE, Marino G, Kuo PC, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl. 2001;7:762-768.
19. Saab S, Chang AJ, Comulada S, et al. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003;9:1053-1061.
20. Saab S, Ghobrial RM, Ibrahim AB, et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant. 2003;3:1167-1172.
21. Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999;117:149-153.
22. Donataccio D, Roggen F, De Reyck C, et al. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Transpl Int. 2006;19:38-43.
23. Jain A, Orloff M, Abt P, et al. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine. Transplant Proc. 2005;37:3187-3189.
24. Shames BD, D'Alessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy? Am J Transplant. 2002;2:658-663.
25. Buell JF, Beebe TM, Trofe J, et al. Donor transmitted malignancies. Ann Transplant. 2004;9:53-56.
26. Buell JF, Trofe J, Sethuraman G, et al. Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003;76:340-343.
27. Feng S, Buell JF, Chari RS, et al. Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant. 2003;3:1481-1487.
28. Levy MF, Somasundar PS, Jennings LW, et al. The elderly liver transplant recipient: a call for caution. Ann Surg. 2001;233:107-113.
29. Ghobrial RM, Gornbein J,Steadman R, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg.2002;236:315- 322; discussion 322-323.
30. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210:649-652.
31. Handschin AE, Weber M, Renner E, et al. Abdominal compartment syndrome after liver transplantation. Liver Transpl. 2005;11:98-100.